| Literature DB >> 31081504 |
Pilar Montero-Alía1,2,3, Ramón Miralles-Basseda3,4, Tomás López-Jiménez3,5, Laura Muñoz-Ortiz6, Mercè Jiménez-González2, Josep Prat-Rovira7, José Luís Albarrán-Sánchez2, Josep Maria Manresa-Domínguez1, Celia Maria Andreu-Concha2, M Carmen Rodríguez-Pérez2, Juan José Martí-Cervantes2, Lidia Sañudo-Blanco2, Carlos Andrés Sánchez-Pérez2, Sònia Dolader-Olivé2, Pere Torán-Monserrat1.
Abstract
BACKGROUND: gamification is a potentially attractive option for improving balance and reducing falls.Entities:
Keywords: Nintendo WiiFitTM; balance; community-dwelling; falls; older adults; quasi-randomized clinical trial
Mesh:
Year: 2019 PMID: 31081504 PMCID: PMC6593319 DOI: 10.1093/ageing/afz047
Source DB: PubMed Journal: Age Ageing ISSN: 0002-0729 Impact factor: 10.668
Figure 1.Flow chart.
Baseline data.
| Whole cohort study | |||
|---|---|---|---|
| Total | Intervention Group | Control Group | |
| Sex, | |||
| Male | 400/977 (40.9) | 192/508 (37.8) | 208/469 (44.3) |
| Female | 577/977 (59.1) | 316/508 (62.2) | 261/469 (55.7) |
| Age, median (p25–p75) | 75.3 (72.6–78.5) | 75.1 (72.6–78.7) | 75.4 (72.7–78.6) |
| BMI, median (p25–p75) | 27.8 (25.1–30.8) | 27.8 (25.5–30.8) | 27.5 (24.8–30.8) |
| Underweight, | 6/963 (0.6) | 1/499 (0.2) | 5/464 (1.1) |
| Normal weight, | 225/963 (23.4) | 103/499 (20.6) | 122/464 (26.3) |
| Overweight, | 432/963 (44.9) | 239/499 (47.9) | 193/464 (41.6) |
| Obesity, | 300/963 (31.1) | 156/499 (31.3) | 144/464 (31.0) |
| Cognitive impairment, | |||
| Without | 902/934 (96.6) | 461/475 (97.1) | 441/459 (96.1) |
| Mild | 32/934 (3.4) | 14/475 (2.9) | 18/459 (3.9) |
| IADL Scale, | 204/970 (21.0) | 106/503 (21.1) | 98/467 (21.0) |
| Dependent (0–7) | 766/970 (79.0) | 397/503 (78.9) | 369/467 (79.0) |
| Independent (8) | |||
| Tinetti’s test, median/ | |||
| Balance | 16/963 (14–16) | 15/499 (14–16) | 16/464 (14–16) |
| Gait | 12/962 (11–12) | 12/499 (11–12) | 12/463 (12-12) |
| Total | 27/960 (26–28) | 27/497 (25–28) | 28/463 (26–28) |
| Unipedal stance test, | |||
| Is able | 762/962 (79.2) | 392/501 (78.2) | 370/461 (80.3) |
| Is unable | 200/962 (20.8) | 109/501 (21.8) | 91/461 (19.7) |
| Balance Wii test %, median/ | 70/965 (37–87) | 70/502 (35–87) | 71/463 (39–86) |
| Patients who had fallen during past year, | |||
| No | 658/970 (67.8) | 312/504 (61.9) | 346/466 (74.2) |
| Yes | 312/970 (32.2) | 192/504 (38.1) | 120/466 (25.8) |
| Has received rehabilitating treatment for gait during the past year, | |||
| No | 907/938 (96.7) | 466/485 (96.1) | 441/453 (97.4) |
| Yes | 31/938 (3.3) | 19/485 (3.9) | 12/453 (2.6) |
| Needs technical assistance to walk, | |||
| No | 844/965 (87.5) | 435/502 (86.7) | 409/463 (88.3) |
| Yes | 121/965 (12.5) | 67/502 (13.3) | 54/463 (11.7) |
| Fear of falling, median/ | 8/934 (7–10) | 8/475 (7–11) | 8/459 (7–10) |
Outcomes between groups at 3 months and 1 year. Whole cohort study.
| Intervention | Control | Differences in groups | Differences between groups | |||
|---|---|---|---|---|---|---|
| Mean (SD) or | Mean (SD) or | Difference in % IG (95%CI)/ | Difference in % CG (95% CI)/ | Change difference % IG–CG (95%CI) | ||
| Baseline | 14.9 (1.7)/499 | 14.8 (2.0)/464 | ||||
| 3 months | 15.2 (1.4)/293 | 15.1 (1.9)/342 | 0.28 (0.09; 0.47)/293 | 0.30 (0.10; 0.50)/342 | −0.02 (−0.30; 0.26) | 0.878 |
| 1 year | 14.9 (1.7/250) | 15.1 (1.9)/295 | 0.08(−0.16; 0.32)/250 | 0.25 (0.04; 0.46)/295 | −0.17 (−0.47; 0.14) | 0.280 |
| Baseline | 11.4 (1.3)/499 | 11.4 (1.8)/463 | ||||
| 3 months | 11.5 (1.3)/288 | 11.4 (1.9)/336 | 0.16 (−0.03; 0.35)/288 | 0.06 (−0.13; 0.25)/336 | 0.10 (−0.17; 0.37) | 0.466 |
| 1 year | 11.1 (2.0)/247 | 11.4 (1.9)/294 | −0.15 (−0.44; 0.14)/247 | 0.07 (−0.17; 0.32)/294 | −0.25 (−0.67; 0.17) | 0.250 |
| Baseline | 26.2 (2.6)/497 | 26.2 (3.5)/463 | ||||
| 3 months | 26.7 (2.4)/288 | 26.5 (3.5)/333 | 0.43 (0.10; 0.76)/288 | 0.38 (0.04; 0.72)/333 | 0.05 (−0.43; 0.53) | 0.835 |
| 1 year | 26.1 (3.3)/246 | 26.4 (3.4)/294 | −0.05 (−0.50; 0.40)/246 | 0.33 (−0.07; 0.73)/294 | −0.38 (−0.98; 0.23) | 0.220 |
| Baseline | 231 (79.7)/501 | 276 (81.7)/461 | ||||
| 3 months | 251 (86.6)/290 | 292 (86.4)/338 | 6.90 (1.20; 12.59)/290 | 4.73 (0.54; 8.93)/338 | 2.16 (−4.36; 8.69) | 0.515 |
| 1 year | 190 (76.3)/249 | 231 (79.1)/292 | −8.03 (−7.60; 6.00)/249 | −2.05 (−6.84; 2.73)/292 | 1.25 (−6.40; 8.90) | 0.748 |
| Baseline | 62.9 (29.3)/502 | 63.8 (28.4)/463 | ||||
| 3 months | 52.1 (32.3)/238 | 53.5 (30.2)/324 | −10.8 (−15.9; −5.7)/238 | −10.4 (−14.7; −6.1)/324 | −0.4 (−7.1; 6.2) | 0.895 |
| 1 year | 49.5 (31.5)/258 | 58.8 (69.1)/293 | −8.74 (−13.9; −3.59)/258 | −2.18 (−10.6; 6.22)/293 | −6.6 (−16.7; 3.6) | 0.205 |
| Baseline | 9.5 (3.2)/475 | 9.0 (3.1)/459 | ||||
| 3 months | 8.9 (2.4)/269 | 9.0 (3.0)/339 | −0.61 (−0.89; −0.32)/269 | 0.06 (−0.19; 0.31)/339 | −0.66 (−1.05; −0.28) | 0.001 |
| 1 year | 9.3 (2.7)/177 | 8.8 (3.1)/249 | −0.60 (−1.06; −0.15)/177 | −0.42 (−0.73; −0.11)/249 | −0.18 (−0.71; 0.35) | 0.499 |
IG, intervention group; CG, control group; SD, standard deviation; CI, confidence interval.